1. Home
  2. EYPT vs UIS Comparison

EYPT vs UIS Comparison

Compare EYPT & UIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • UIS
  • Stock Information
  • Founded
  • EYPT 1987
  • UIS 1942
  • Country
  • EYPT United States
  • UIS United States
  • Employees
  • EYPT N/A
  • UIS N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • UIS EDP Services
  • Sector
  • EYPT Industrials
  • UIS Technology
  • Exchange
  • EYPT Nasdaq
  • UIS Nasdaq
  • Market Cap
  • EYPT 439.4M
  • UIS 474.3M
  • IPO Year
  • EYPT 2005
  • UIS N/A
  • Fundamental
  • Price
  • EYPT $9.17
  • UIS $7.49
  • Analyst Decision
  • EYPT Strong Buy
  • UIS
  • Analyst Count
  • EYPT 8
  • UIS 0
  • Target Price
  • EYPT $27.29
  • UIS N/A
  • AVG Volume (30 Days)
  • EYPT 1.1M
  • UIS 923.8K
  • Earning Date
  • EYPT 11-07-2024
  • UIS 10-29-2024
  • Dividend Yield
  • EYPT N/A
  • UIS N/A
  • EPS Growth
  • EYPT N/A
  • UIS N/A
  • EPS
  • EYPT N/A
  • UIS N/A
  • Revenue
  • EYPT $45,713,000.00
  • UIS $2,020,600,000.00
  • Revenue This Year
  • EYPT N/A
  • UIS $0.92
  • Revenue Next Year
  • EYPT N/A
  • UIS $2.90
  • P/E Ratio
  • EYPT N/A
  • UIS N/A
  • Revenue Growth
  • EYPT 7.50
  • UIS 0.29
  • 52 Week Low
  • EYPT $5.86
  • UIS $3.32
  • 52 Week High
  • EYPT $30.99
  • UIS $8.49
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 38.25
  • UIS 56.51
  • Support Level
  • EYPT $11.26
  • UIS $7.87
  • Resistance Level
  • EYPT $12.23
  • UIS $8.42
  • Average True Range (ATR)
  • EYPT 0.97
  • UIS 0.45
  • MACD
  • EYPT -0.30
  • UIS 0.03
  • Stochastic Oscillator
  • EYPT 3.24
  • UIS 68.25

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About UIS Unisys Corporation New

Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides solutions that transform digital workplaces securely and create exceptional end-user experiences. CA&I provides digital platform, applications and infrastructure solutions. ECS provides solutions that harness secure, continuous high-intensity computing and enable digital services through software-defined operating environments.

Share on Social Networks: